Schoenberg Mark
Transaction: 06/08/2026
SELL
Change
-10,000
Price
Not reported
Filing
06/09/2026
Type
SELL
UroGen Pharma Ltd.
URGN • Biotechnology
$35.01
▲ +0.86 (+2.52%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$1.76B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 4.01Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 6, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$35.01
Change2.52%
Shares Out50.18M
Market Cap$1.76B
Enterprise Value$1.81B
52W Range12.73 - 35.56
Beta1.36
P/E-13.19
P/S12.51
P/B-14.14
P/FCF-10.58
EV/Sales12.86
Price$35.01
Change2.52%
Shares Out50.18M
Market Cap$1.76B
Enterprise Value$1.81B
52W Range12.73 - 35.56
Beta1.36
P/E-13.19
P/S12.51
P/B-14.14
P/FCF-10.58
EV/Sales12.86
EV/EBITDA-15.52
EV/FCF-10.88
Earnings Yield-7.58%
FCF Yield-9.45%
Dividend Yield0.00%
Gross Margin88.66%
Oper. Margin-113.73%
Profit Margin-139.81%
Debt/Eq-1.22
Current Ratio4.01
Quick Ratio3.65
Target$56.60
Target Upside61.67%
Target Median$56.00
Target Range44.00 - 75.00
Volume461.32K
Avg Volume789.20K
EPS Surprise0.09
Investment DNA
How strong this company looks for long-term investors
31
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
35/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Healthy liquidity · 4.01Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 16 analyst votes · 2026-10-21
88/100
Bullish
Bullish
12
Hold
4
Bearish
0
Price Target
2026-06-24
Low
$40.00
Mean
$42.50
Median
$42.50
High
$45.00
Insider Transactions
Recent executive and insider activity
Schoenberg Mark
Transaction: 06/08/2026
SELL
Change
-5,222
Price
$27.30
Filing
06/09/2026
Type
SELL
Robinson James A. Jr.
Transaction: 05/26/2026
SELL
Change
-2,000
Price
Not reported
Filing
05/27/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Schoenberg Mark | SELL | -10,000 | Not reported | 06/08/2026 | 06/09/2026 |
| Schoenberg Mark | SELL | -5,222 | $27.30 | 06/08/2026 | 06/09/2026 |
| Robinson James A. Jr. | SELL | -2,000 | Not reported | 05/26/2026 | 05/27/2026 |
| Robinson James A. Jr. | BUY | +2,000 | Not reported | 05/26/2026 | 05/27/2026 |
| Schoenberg Mark | SELL | -10,000 | $30.00 | 05/08/2026 | 05/11/2026 |
| Robinson James A. Jr. | SELL | -2,000 | Not reported | 02/26/2025 | 02/27/2026 |
| Robinson James A. Jr. | BUY | +2,000 | Not reported | 02/26/2025 | 02/27/2026 |
| Barrett Elizabeth A. | BUY | +153,195 | Not reported | 01/31/2026 | 02/19/2026 |
| Smith Jason Drew | SELL | -1,608 | $19.69 | 02/03/2026 | 02/11/2026 |
| Smith Jason Drew | SELL | -6,667 | Not reported | 01/31/2026 | 02/11/2026 |
| Smith Jason Drew | BUY | +6,667 | Not reported | 01/31/2026 | 02/11/2026 |
| Schoenberg Mark | SELL | -3,686 | $19.69 | 02/03/2026 | 02/04/2026 |
| Degnan Chris | BUY | +32,609 | Not reported | 01/31/2026 | 02/03/2026 |
| Schoenberg Mark | SELL | -3,334 | Not reported | 01/31/2026 | 02/03/2026 |
| Schoenberg Mark | BUY | +3,334 | Not reported | 01/31/2026 | 02/03/2026 |
| Wildman Daniel George | BUY | +2,000 | Not reported | 11/26/2025 | 12/01/2025 |
| Wildman Daniel George | SELL | -2,000 | Not reported | 11/26/2025 | 12/01/2025 |
| WEN LEANA | BUY | +2,000 | Not reported | 11/26/2025 | 12/01/2025 |
| WEN LEANA | SELL | -2,000 | Not reported | 11/26/2025 | 12/01/2025 |
| Robinson James A. Jr. | BUY | +2,000 | Not reported | 11/26/2025 | 12/01/2025 |